Portfolio company
LYLA
Netherlands
Raised
Undisclosed
Latest stage
Pre-seed
Rounds recorded
1 · 1 undisclosed
Backed by
1 investor
Sectors
About
LYLA produces automated scanners for the quality control of radiopharmaceuticals to support hospitals and clinics providing cancer treatments.
SourceFunding history · 1
Similar companies
Rocket Isotopes AG
The company produces medical radioisotopes for pharmaceutical firms and clinical trials to facilitate radioligand therapies for cancer patients.
Limula
Limula develops an automated platform for manufacturing cell and gene therapies to assist therapy developers, hospitals and clinical centres with decentralized production.
Actithera
This biotechnology company develops targeted radioligand therapies to treat cancer patients by delivering radioactive isotopes directly to solid tumours.
Atley Solutions
The company manufactures automated systems and radiochemical supplies for pharmaceutical developers to produce astatine-211 cancer therapies.
LEUKO
This company develops a non-invasive device for monitoring white blood cell levels at home for cancer patients undergoing chemotherapy.
Leo Cancer Care
This company manufactures upright radiotherapy and imaging systems for hospitals and cancer treatment centres to improve patient positioning and reduce equipment costs.
LitePharmTech
This company develops and manufactures photosensitisers, antioxidant injections and ophthalmic solutions for university hospitals and patients requiring cancer treatment or immune support.
ROTOP
This company manufactures radiopharmaceuticals and cold kits for diagnostic imaging and cancer therapy, serving hospitals, clinics, and pharmaceutical research partners globally.
